FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (1), its pharmaceutically acceptable salts, and also to pharmaceutical compositions containing the compound as an active ingredient; and a method of treating, alleviating or preventing diseases using said compound. (I).
EFFECT: obtaining novel compounds that are useful for treating, alleviating or preventing diseases caused by abnormal or uncontrolled activation of protein kinase, such as BTK.
23 cl, 5 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS SUITABLE AS KINASE INHIBITORS FOR TREATMENT OF PROLIFERATIVE DISEASES | 2012 |
|
RU2664055C2 |
DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS SUITABLE AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | 2018 |
|
RU2804468C2 |
ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
BICYCLIC HETEROCYCLIC DERIVATIVES, THEIR PRODUCTION AND APPLICATION | 2013 |
|
RU2627269C2 |
DIPHENYL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1997 |
|
RU2175319C2 |
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USE THEREOF | 2016 |
|
RU2743360C2 |
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
HETEROARYL COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF AS PROTEIN KINASE INHIBITORS | 2007 |
|
RU2474582C2 |
Authors
Dates
2018-11-07—Published
2013-12-26—Filed